Brian Feinstein, DO
Dermatology · Delray Beach, FLNPI 1780802595
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,550 of the $7,540 with a category attached, or 60.3%. AbbVie accounts for 74.9% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $5,335, more than ten times the $46 reported in 2019.
Across 135 payments — averaging $55.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Sanofi$283
- Regeneron Healthcare Solutions, Inc.$245
- Novartis$169
- Galderma Laboratories, L.p.$166
- Amgen$163
- plus $867 from 14 others
Across 671 payments — averaging $5410.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$1.5M
- Pfizer$799K
- Incyte Corporation$468K
- Eli Lilly$436K
- E.r. Squibb & Sons, L.L.C.$152K
- AbbVie$131K
- plus $109K from 2 others
What the payments were for
- Speaking & faculty fees$4,55060%
- Food & beverage$2,96039%
- Education$310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 50 | $5,647 |
| Sanofi | 10 | $283 |
| Regeneron Healthcare Solutions, Inc. | 10 | $245 |
| Novartis | 8 | $169 |
| Galderma Laboratories, L.p. | 9 | $166 |
| Amgen | 7 | $163 |
| Johnson & Johnson | 7 | $158 |
| UCB, Inc. | 5 | $134 |
| Pfizer | 7 | $117 |
| Incyte Corporation | 5 | $111 |
| Boehringer Ingelheim | 3 | $81 |
| Sun Pharmaceutical Industries Inc. | 3 | $50 |
| Strata Skin Sciences, Inc. | 3 | $40 |
| Almirall LLC | 2 | $34 |
| Kerecis Limited | 1 | $30 |
| Organogenesis Inc. | 1 | $25 |
| Taro Pharmaceuticals USA, Inc. | 1 | $24 |
| LEO Pharma Inc. | 1 | $24 |
| DUSA Pharmaceuticals, Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,540 in reported general payments places this provider in the 75th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $62,256 |
| Mupirocin | 746 | $4,603 |
| Doxycycline Hyclate | 463 | $4,128 |
| Ketoconazole | 240 | $3,449 |
| Gentamicin Sulfate | 85 | $3,276 |
| Triamcinolone Acetonide | 224 | $2,152 |
| Metronidazole | 42 | $1,937 |
| Fluorouracil | 25 | $1,664 |
| Fluocinonide | 42 | $1,576 |
| Clobetasol Propionate | 32 | $1,438 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 80 | $1,373 |
| Clindamycin Phosphate | 46 | $1,128 |
| Betamethasone Dipropionate | 17 | $739 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 56 | $595 |
| Famciclovir | 14 | $401 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Delray Beach
- John StrasswimmerDelray Beach$560K
- Janet AllenbyDelray Beach$459K
- Francesca LewisDelray Beach$175K
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.